NP-05

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameNP-05
Drug Alias Namestrontium (Medesis)NP-05
ClassificationSmall molecules > Lipid
Mechanisms of ActionBone modulators
TargetsUpdating
Therapy Area/IndicationsOsteoporosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMedesis Pharma Sa
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMedesis Pharma Sa
Active IndicationsN/A
Inactive IndicationsOsteoporosis

Other Information

ATC CodeN/A
Related LinksN/A